Johnson & Johnson Vision Care, Inc.

42 articles with Johnson & Johnson Vision Care, Inc.

• New Prospective Study Shows Significant Reduction In Reports Of Postoperative Halos From Patients Treated With TearScience LipiFlow Treatment Prior To Bilateral Cataract Surgery

  7/24/2021

  Johnson & Johnson Vision*, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies**, revealed new comparative clinical study findings evaluating TearScience LipiFlow treatment in cataract surgery.

• Johnson & Johnson Vision Introduces VERITAS Vision System With Features To Address Key Unmet Needs In Cataract Surgery

  7/23/2021

  Johnson & Johnson Vision today announced the global availability of the VERITAS Vision System, a next-generation phacoemulsification (phaco) system designed to address three critical areas: patient safety, surgeon efficiency and comfort.

• Johnson & Johnson Vision Presents Scientific Data Validating Improved Surgical Outcomes With Latest Cataract Innovations And Legacy MGD Treatment At The 2021 ASCRS•ASOA Annual Meeting

  7/20/2021

  New Evidence Evaluating the TECNIS Family of IOLs, including TECNIS Synergy and TECNIS Toric II, to be Presented in 10 Oral and 3 Poster Presentations

• Johnson & Johnson Vision Expands "Sight For Kids" Program to Bring Eye Care to More Children and Unveils New "Vision for Good" Community Impact Report

  6/2/2021

  Johnson & Johnson Vision,* a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies,** announced the expansion of nonprofit program Sight For Kids.

• Johnson & Johnson Vision Announces FDA Approval of ACUVUE® Abiliti™ Overnight Therapeutic Lenses for Myopia Management

  5/12/2021

  - First and only FDA-approved orthokeratology contact lens for myopia management. - Available in sphere and toric designs to correct various combinations of corneal shapes and refractive errors.

• Johnson & Johnson Vision Receives FDA Clearance and CE Mark for Next-Generation Phacoemulsification Machine, VERITAS™ Vision System

  4/21/2021

  VERITAS™ Vision System to introduce innovations in fluidics management and usability to fuel surgeons' performance in every cataract procedure, from the easiest to most challenging

• Johnson & Johnson Vision Announces Global Collaboration with Menicon to Bring Forward Contact Lenses to Help Manage the Progression of Myopia in Children

  4/7/2021

  This new collaboration combines expertise from Menicon Co., Ltd., a world-class manufacturer of innovative contact lenses with the science, scale and capabilities of Johnson & Johnson Vision

• Johnson & Johnson Vision Introduces New ACUVUE® OASYS MULTIFOCAL with PUPIL OPTIMIZED DESIGN and Expands the ACUVUE® OASYS Portfolio of Offerings for Patients with Presbyopia

  3/15/2021

  - Newest member of the ACUVUE® OASYS Brand Family designed to deliver crisp, clear reliable vision at all distances, regardless of age or refractive error¹. - The new lens is designed for superior visual performance and a more precise fit∞¹.

• Johnson & Johnson Vision Celebrates 20 Years of Helping Cataract Patients with the See More Campaign and Global Patient Story Search

  2/9/2021

  The TECNIS® portfolio is the broadest mix of IOLs available worldwide, providing solutions for a variety of visual conditions to allow patients to See More

• New Survey on Eye Health Finds Most People Say They Know the Importance of an Annual Eye Exam, but - They Actually Don't and They're Not Getting One

  10/6/2020

  While the majority of people said they agree an eye exam is important for overall health, many don't know why and aren't taking proactive measures to keep their eyes healthy

• Johnson & Johnson Vision Introduces TECNIS Toric II 1-Piece IOL as New Monofocal Option for Cataract Patients with Astigmatism; Launching Multi-Center, Post-Market Clinical Trials Across U.S.

  12/3/2019

  Johnson & Johnson Vision*, a global leader in eye health, announced the Food and Drug Administration approval and U.S. launch of TECNIS Toric II 1-Piece Intraocular Lens.

• Johnson & Johnson Vision Care, Inc. Introduces ACUVUE™ RevitaLens Multi-Purpose Disinfecting Solution, the Brand's First Contact Lens Solution

  9/30/2019

  ACUVUE™ RevitaLens MPDS Delivers Exceptional Contact Lens Disinfection and All-Day Comfort   [30-September-2019]   JACKSONVILLE, Fla. , Sept. 30, 2019 /PRNewswire/ -- Johnson & Johnson Vision †  is excited to unveil the first-ever extension of the ACUVUE ® brand name beyond contact lenses with today's launch of ACUVUE™ RevitaLens Multi-Purpose Disinfecting Solution (MP

• Johnson & Johnson Vision Announces Availability of ACUVUE OASYS with TRANSITIONS LIGHT INTELLIGENT TECHNOLOGY in the U.S.

  3/27/2019

  Baseball Superstar Bryce Harper Named Ambassador for New Contact Lenses that Seamlessly Adapt to Changing Light Conditions[1]

• Johnson & Johnson Vision's Investigational Antihistamine-Releasing Contact Lens Demonstrates Positive Phase 3 Results

  3/26/2019

  Two placebo-controlled studies published in Cornea show potential for contact lenses to correct vision and reduce occurrence of eye itch from allergies

• Two Studies Measure Performance of ACUVUE OASYS with Transitions Light Intelligent Technology Contact Lenses in Simulated Sunlight, Day and Night Driving Conditions

  11/6/2018

  First-of-its-kind photochromic contact lens delivered improved visual function compared to transparent contact lenses in simulated sunlight

• New Data from Johnson & Johnson Vision Highlights the Need and Potential Standards for Evidence-Based Decision-Making in Myopia

  11/5/2018

  Two meta-analyses, including first of its kind focused on myopic children, will be presented at the 2018 American Academy of Optometry Annual Meeting

• Johnson & Johnson Vision Launches MyACUVUE Subscription Program

  10/23/2018

  Johnson & Johnson Vision Care, Inc. today announced the launch of its MyACUVUE Subscription Program, developed to provide contact lens wearers greater access and convenience when purchasing an annual supply of ACUVUE Brand contact lenses through their eye care professional.

• Johnson & Johnson Vision Launches Next Generation of Personalized LASIK Treatment, iDESIGN Refractive Studio Now Available

  9/6/2018

  Next generation LASIK platform with technology that analyzes the entire eye inside and out for a truly personalized treatment

• FDA Approves the Next Generation of Customized LASIK Treatment with iDESIGN Refractive Studio

  6/18/2018

  Johnson & Johnson Vision announced today the U.S. Food and Drug Administration (FDA) approval of the iDESIGN Refractive Studio

• Johnson & Johnson Vision Presents New Studies Revealing Antioxidant Properties of Ultraviolet Blocker in ACUVUE® Brand Contact Lenses

  5/1/2018

  Johnson & Johnson Vision today presented new data on the discovery of antioxidant properties of the ultraviolet (UV) blocker in ACUVUE® Brand Contact Lenses at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Honolulu, Hawaii.